Lund-Mackay CT Score for Chronic Rhinosinusitis
Radiological staging system for chronic rhinosinusitis using CT sinus scoring. Each sinus scored 0-2. Maximum score 24.
Score interpretation
Lund-Mackay 0–3: Mild or minimal sinus disease.
→ Conservative management: intranasal corticosteroid spray (mometasone or fluticasone) for ≥ 3 months. Nasal saline douching. ENT review if symptoms persist.
Lund-Mackay 4–11: Moderate chronic rhinosinusitis.
→ Topical intranasal steroids (high-dose). Consider short course oral steroids for nasal polyps. Assess for allergic component. ENT review — consider functional endoscopic sinus surgery (FESS) if persistent.
Lund-Mackay ≥12: Severe sinonasal disease — extensive opacification.
→ ENT surgeon referral for FESS evaluation. Pre-operative steroid preparation. Post-operative sinonasal care essential. Exclude aspirin-exacerbated respiratory disease (AERD) / Samter's triad.
Interpretation bands for the Lund-Mackay. Apply clinical judgement and local guidance.
References
- Lund VJ, Mackay IS. Staging in rhinosinusitis. Rhinology. 1993.
- EPOS 2020: European Position Paper on Rhinosinusitis and Nasal Polyps.
Related
Curated clinical cross-links plus same-class fallbacks.
- Sodium Chloride 0.9% Nasal Irrigation / Spray · Nasal irrigation / saline decongestant (non-pharmacological adjunct)
- Mupirocin 2% Ointment · Topical antibiotic (pseudomonic acid)
- Omalizumab (Dermatology — Chronic Urticaria) · Anti-IgE Monoclonal Antibody
- Chlorhexidine with neomycin · Topical nasal antiseptic/antibiotic
- Glucagon · Hypoglycaemia Antidote / Endocrine Agent
- Amoxicillin (Otitis Media / Sinusitis) · Beta-lactam antibiotic
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.